Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(6S,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42S,48S,51S,54S)-1,6-diamino-18,21,33,39,42,51,54-heptakis(4-aminobutyl)-15,48-dibenzyl-36-sec-butyl-30-(3-guanidinopropyl)-1-imino-12,24,27-triisobutyl-7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52-hexadecaoxo-2,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53-heptadecaazapentapentacontan-55-oic acid
ID: ALA5282903
Chembl Id: CHEMBL5282903
Max Phase: Preclinical
Molecular Formula: C100H178N30O18
Molecular Weight: 2088.72
Associated Items: